| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1016845212 |
| P356 | DOI | 10.1186/S12886-015-0122-Z |
| P932 | PMC publication ID | 4604775 |
| P698 | PubMed publication ID | 26462481 |
| P5875 | ResearchGate publication ID | 283778607 |
| P2093 | author name string | Thomas M Lietman | |
| Nisha R Acharya | |||
| Jennifer Rose-Nussbaumer | |||
| Aileen Sy | |||
| Kieran S O'Brien | |||
| Puja A Cuddapah | |||
| Margaret P Liu | |||
| P2860 | cites work | The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study | Q45284543 |
| A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome | Q46321286 | ||
| Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients | Q46816870 | ||
| Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. | Q50504091 | ||
| The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy. | Q50524947 | ||
| Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. | Q50566871 | ||
| Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sjögren's syndrome. | Q51420681 | ||
| Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome. | Q55056224 | ||
| The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347909 | ||
| Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye | Q82285158 | ||
| Clinical treatment of dry eye using 0.03% tacrolimus eye drops | Q83914191 | ||
| Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial | Q84472814 | ||
| Punctal occlusion for dry eye syndrome | Q24235284 | ||
| Ophthalmologist perceptions regarding treatment of moderate to severe dry eye: results of a physician survey. | Q33623447 | ||
| Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study | Q34066784 | ||
| Spatial epidemiology of dry eye disease: findings from South Korea | Q34070100 | ||
| Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years | Q34443357 | ||
| Improvement of dry eye symptoms with polyunsaturated fatty acids | Q34577962 | ||
| Topical omega-3 and omega-6 fatty acids for treatment of dry eye. | Q34749224 | ||
| Acanthamoeba keratitis: multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group | Q35303382 | ||
| Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease | Q35592019 | ||
| A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients | Q36296284 | ||
| Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study | Q36313759 | ||
| Sjögren keratoconjunctivitis sicca treated with rituximab. | Q36898438 | ||
| Dry eye disease: an immune-mediated ocular surface disorder | Q36916372 | ||
| Advances in understanding and managing dry eye disease | Q37206550 | ||
| Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops | Q37208060 | ||
| Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea | Q37309955 | ||
| The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome | Q37607603 | ||
| Treatment of Sjögren's syndrome-associated dry eye an evidence-based review | Q37860700 | ||
| Clinical guidelines for management of dry eye associated with Sjögren disease. | Q38424517 | ||
| Attitudes towards diagnostic tests and therapies for dry eye disease. | Q39030845 | ||
| The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study | Q39211271 | ||
| Efficacy of doxycycline and tetracycline in ocular rosacea. | Q39492430 | ||
| A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. | Q40720490 | ||
| Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group | Q40765221 | ||
| Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group | Q41730611 | ||
| Oxytetracycline in the treatment of ocular rosacea: a double-blind trial | Q42608648 | ||
| Controlled study of the use of autologous serum in dry eye patients. | Q43783612 | ||
| Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. | Q44327659 | ||
| Antiinflammatory therapy for dry eye. | Q44763839 | ||
| Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome | Q45034864 | ||
| A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance | Q45056544 | ||
| Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. | Q45122469 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 133 | |
| P577 | publication date | 2015-10-13 | |
| P1433 | published in | BMC Ophthalmology | Q15765692 |
| P1476 | title | Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED). | |
| P478 | volume | 15 |
| Q26752848 | Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease |
| Q37485838 | Corneal sensitivity, ocular surface health and tear film stability after punctal plug therapy of aqueous deficient dry eye. |
| Q61454863 | Current Management and Treatment of Dry Eye Disease |
| Q57378488 | Current and emerging therapy of dry eye disease. Part A: pharmacological modalities |
| Q89493291 | Effectiveness Of Polyethylene Cover Versus Polyethylene Cover With Artificial Tear Drop To Prevent Dry Eye In Critically Ill Patients: A Randomized Controlled Clinical Trial |
| Q88366341 | Expert practice patterns and opinions on corneal cross-linking for infectious keratitis |
| Q91788702 | Preliminary In Vivo Safety Evaluation of a Tacrolimus Eye Drop Formulation Using Hydroxypropyl Beta Cyclodextrin After Ocular Administration in NZW Rabbits |
| Q41352146 | The role of lipids in corneal diseases and dystrophies: a systematic review |
| Q50110517 | Therapeutic inhibitors for the treatment of dry eye syndrome. |
Search more.